Showing results (471-480 of 482) with videos related to

Sort By:
Pageof 49
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational ImpactMichele Carbone, Christopher Amos, Richard L Attanoos, et al.
American Journal of Respiratory and Critical Care Medicine|January 16, 2016
Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary DiseaseBrian D Hobbs, Margaret M Parker, Han Chen, et al.
Ebiomedicine|October 26, 2019
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactionsNicolas Alcala, Lise Mangiante, Nolwenn Le-Stang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 30, 2018
Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research FoundationAnne S Tsao, O Wolf Lindwasser, Alex A Adjei, et al.
Cancer Immunology Research|June 12, 2025
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor That Unleashes PD-1 Checkpoint and CAR T-Cell ImmunotherapiesMichael Wichroski, Si-Qi Liu, Lauren M Zasadil, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Nature Medicine|June 27, 2020
Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumorsMichal Slyper, Caroline B M Porter, Orr Ashenberg, et al.
Nature Medicine|May 15, 2020
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumorsMichal Slyper, Caroline B M Porter, Orr Ashenberg, et al.
Cancer Immunology Research|June 9, 2022
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H Knelson, Elena V Ivanova, Mubin Tarannum, et al.
Pageof 49